NeuroD1-based gene therapy could potentially be used to treat stroke, which is a leading cause of disability in the US, with 800,000 new stroke patients every year
Microchannel cell-trapping device rapidly identifies antimicrobial susceptibility directly from clinical samples at the single cell level
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.